Skip to main content
. 2018 Mar 26;98(6):1714–1717. doi: 10.4269/ajtmh.18-0009

Table 2.

Prevalence and frequency of SNPs at the Pfdfhr and Pfdhps genes

Codon SNPs Prevalence Frequency
Evaluable sample (N) Number with specific SNP (n) % (n/N × 100) Evaluable sample (N) Number with specific SNP (n) % (n/N × 100)
Pfdhfr
 50/51 CN 142 36 25.5 136 33 24.3
CI 142 106 75.5 136 103 75.7
 59 C 146 24 16.4 140 21 15.0
R 146 122 83.6 140 119 85.0
 108 S 139 17 12.2 139 17 12.2
N 139 122 87.8 139 122 87.8
T 0 0
 164 I 132 132 100.0 132 132 100.0
L 0 0
Pfdhps
 436/437 AA 147 3 2.0 141 3 2.1
AG 95 64.6 95 67.4
SA 3 2.0 1 0.7
SG 45 30.6 41 29.1
FA 1 0.7 1 0.7
 540 K 143 142 99.3 141 141 100.0
E 1 0.7 0
 581 A 152 147 96.7 150 146 97.3
G 5 3.3 4 2.7
 613 A 148 138 93.2 146 137 93.8
S 10 6.8 9 6.2
Pfdhfr and Pfdhps haplotypes*
Pfdhfr (N = 126)
  CIRNI 97 77
  CNCSI 9 7.1
Pfhdps (N = 130)
  AGKAA 80 61.5
  SGKAA 39 30
  AGKAS 6 4.6
  AGKGS 1 0.8
  AAKAA 3 2.3
  SAKAA 1 0.8
Pfdhfr/ (N = 81)
  CIRNI/AGKAA (quadruple mutation) 42 51.9
  CIRNI/SGKAA (quadruple mutation) 33 40.7
  CIRNI/AGKAS (quintuple mutation) 5 6.2
  CIRNI/AGKGS (sextuple mutation) 1 1.2

SNPs = single nucleotide polymorphisms.

*

Only frequencies are reported for haplotypes and N is evaluable samples whereas n is the number of haplotypes.

The Pfdhfr double mutations (CNRNI + CICNI + CIRSI) collectively constituted 15.9%.